![]() |
市场调查报告书
商品编码
1399716
检体采集卡市场 - 副产品(基于棉花和纤维素、纤维为基础)、检体(血液、唾液、尿液)、应用(传染病检测、新生儿筛检)、最终用途 - 全球预测,2023-2032 年Specimen Collection Cards Market - By Product (Cotton & Cellulose-based, Fiber-based), Specimen (Blood, Saliva, Urine), Application (Infectious Disease Testing, Newborn Screening), End-use - Global Forecast, 2023-2032 |
由于对高效诊断程序的日益重视,预计 2023 年至 2032 年标本采集卡市场的CAGR将达到 5%。样本采集卡能够简化样本采集、运输和存储,有助于简化诊断流程。这在医疗保健环境中尤其重要,因为快速且准确的样本采集对于及时诊断和治疗至关重要。
该产品可用于保存 DNA、RNA 或蛋白质以进行分子测试,使其在研究和诊断实验室中不可或缺。各种疾病的分子诊断技术的日益采用推动了市场需求。 2022 年 6 月,生物研究完整样品保护的领导者 GenTegra LLC 推出了 RNAdvantage,这是其套件中最新的 RNA 稳定产品。透过此次推出,GenTegra 产品可以稳定和保护新鲜组织样本和纯化液体 RNA 中有价值的 RNA。
全球标本采集卡产业根据产品类型、标本类型、应用、最终用途和地区进行细分。
由于纤维在样品保存和运输方面的优势,预计到 2032 年,基于纤维的细分市场将获得动力并以强劲的CAGR成长。这些卡片为标本储存提供了稳定的环境,防止核酸降解并确保生物样本的完整性。此外,纤维基材料的环保特性与人们对永续和可生物降解产品的日益重视相一致,从而满足了产品需求。
由于样本采集的便利性和非侵入性,尿液细分市场将在 2023 年和 2032 年显着成长。专为尿液样本设计的卡提供了一种用户友好的方法来收集和保存样本,无需专门的设备或侵入性操作。这种简单性使得它们在各种诊断应用中特别有吸引力,包括药物测试、怀孕测试和疾病监测。易于使用,加上能长时间稳定尿液样本的能力,将有利于样本采集卡的使用。
在慢性病盛行率不断上升和对预防性医疗保健日益关注的支持下,欧洲标本采集卡产业规模将在 2023 年和 2032 年显着增长。个人化医疗和分子诊断的进步进一步推动了产品需求,特别是在基因组学和传染病检测等应用中。欧洲医疗保健产业严格的法规和品质标准强调了可靠和标准化样本收集方法的重要性,从而刺激了区域市场的成长。
Specimen Collection Cards Market is estimated to observe 5% CAGR from 2023 to 2032, driven by increasing emphasis on efficient diagnostic procedures. Specimen collection cards, with their ability to simplify sample collection, transport, and storage, contribute to streamlined diagnostic processes. This is particularly crucial in healthcare settings where quick and accurate sample collection is essential for timely diagnosis and treatment.
The product finds application in preserving DNA, RNA, or proteins for molecular testing, making it indispensable in research and diagnostic laboratories. The growing adoption of molecular diagnostic techniques for various diseases fuels the market demand. In June 2022, GenTegra LLC, a leader of complete sample protection for biological research, launched RNAdvantage, the latest RNA stabilization products in their suite. With this launch, GenTegra products can stabilize and protect valuable RNA in fresh tissue samples and purified liquid RNA.
The worldwide specimen collection cards industry is segmented based on product type, specimen type, application, end-use, and region.
Fiber-based segment is anticipated to gain momentum and grow at a strong CAGR through 2032, owing to its advantages in sample preservation and transportation. These cards provide a stable environment for specimen storage, preventing degradation of nucleic acids and ensuring the integrity of biological samples. Additionally, the eco-friendly nature of fiber-based materials aligns with the increasing emphasis on sustainable and biodegradable products, contributing to the product demand.
Urine segment will record notable growth during 2023 and 2032, due to the convenience and non-invasive nature in sample collection. The cards designed for urine samples provide a user-friendly method for collecting and preserving specimens without the need for specialized equipment or invasive procedures. This simplicity makes them particularly attractive in various diagnostic applications, including drug testing, pregnancy testing, and disease monitoring. The ease of use, coupled with the ability to stabilize urine samples for extended periods, will favor the usage of specimen collection cards.
Europe specimen collection cards industry size will witness significant growth throughout 2023 and 2032, backed by the increasing prevalence of chronic diseases and the rising focus on preventive healthcare. The advancements in personalized medicine and molecular diagnostics further fuel the product demand, especially in applications including genomics and infectious disease testing. Stringent regulations and quality standards in the European healthcare sector underscore the importance of reliable and standardized sample collection methods, stimulating the regional market growth.